Is retinol safe to use on the scalp, or should it be diluted to avoid irritation?

When considering applying retinol to the scalp, it is important not to assume that the effects seen on facial skin automatically apply to this different biological environment. Retinol, a form of vitamin A, is powerful because it alters how skin cells behave. It increases the speed of cell turnover, influences how cells grow and mature, and interacts with molecular pathways deeper within the skin. These characteristics have led to interest in whether retinol could improve scalp condition or enhance the effects of hair growth treatments. However, these same mechanisms also raise concerns about safety, particularly in a sensitive area like the scalp.

Retinoids, which include retinol, retinaldehyde, and stronger compounds such as tretinoin, bind to retinoic acid receptors within the cell nucleus. These receptors act as switches that modify the activity of genes responsible for cell growth, differentiation, and maintenance of the skin barrier. A clinician’s review describes how retinoids bind these receptors to influence how skin cells multiply and mature (Motamedi et al. 2022). In practice, they also often make the skin more reactive and sensitive. This becomes especially relevant when applying retinoids to the scalp, which has a different structure and function than facial skin.

In laboratory studies using human hair follicles outside the body, the combination of retinol and minoxidil resulted in greater hair shaft growth than minoxidil alone (Yoo et al. 2007); a similar lab result was reported for tretinoin plus minoxidil (Kwon et al. 2007). The research showed increased activation of signaling pathways associated with cell survival and growth. However, since these experiments were conducted in vitro, they cannot predict how real human scalps will respond. In a small randomized trial in men, 5% minoxidil plus 0.01% tretinoin once daily showed no significant difference from 5% minoxidil twice daily, and itch or irritation occurred in 5 of 15 vs 4 of 14. The trial was too small to show the two are equally well tolerated (Shin et al. 2007).

Clinical Research on Skin Irritation

Human studies consistently report that retinoids can cause irritation. A study in human skin showed that retinoids trigger epidermal hyperplasia, meaning that the outer layer of the skin thickens. This response was linked to increased activity of epidermal growth factor receptors (Rittié et al. 2006). Other studies have also shown redness, dryness, burning sensations, and peeling among participants using topical retinoids.

Two small randomized split-face studies on healthy facial skin compared tretinoin and adapalene products over two to three weeks and scored redness, dryness and burning. Irritation scores differed between products and strengths (Leyden et al. 2008). Irritation depends on the retinoid, its concentration, the formulation and individual skin sensitivity.

These studies help explain why irritation is common. Retinoids disrupt the skin’s protective barrier and alter the normal structure and behavior of the outermost skin layer. When this happens on the scalp, where the skin is thinner in certain areas and contains many hair follicles and oil glands, the potential for discomfort may be even higher.

Findings Specific to the Scalp

In a 2019 study, 5 days of topical tretinoin raised follicular sulfotransferase levels, the enzymes that convert minoxidil into its active form. The enzyme test reclassified 43% of people predicted not to respond to minoxidil as predicted responders. Hair growth was not measured (Sharma et al. 2019). Although this points to a possible benefit, it also means that retinoids directly alter biological processes inside the follicle. The long-term consequences of this type of biochemical shift are unknown.

These studies do not show that retinoids improve the results of hair growth treatments in people. They also suggest a risk of irritation and possibly longer-term changes in scalp biology. Critically, most research focuses on short-term outcomes and does not evaluate prolonged use on the scalp.

Do We Have Clear Answers Yet?

From a scientific perspective, using retinol on the scalp is still experimental. Lab studies suggest it could interact with hair growth treatments, but human evidence of extra benefit is lacking, and so is evidence for long-term scalp safety. The scalp is a complex tissue, and topical retinoids could affect its protective barrier, hydration levels, and immune responses over time. Without large-scale clinical trials that evaluate long-term use, retinol cannot be described as entirely safe for the scalp.

No study has tested whether diluting retinol reduces irritation on the scalp. Anyone using retinoids on the scalp should understand that research is still limited. The mechanism is plausible but unproven for hair, while the risk of irritation and unknown long-term effects remains real.

Retinoids and Pregnancy

Oral isotretinoin causes severe birth defects and is contraindicated in pregnancy (US label boxed warning). It can also cause hair loss, which sometimes persists (DailyMed, Amnesteem label). For topical retinoids, a meta-analysis of 654 exposed pregnancies found no statistically significant rise in major birth defects (odds ratio 1.22, 95% CI 0.65–2.29), but the authors say it was too small to show that using them in pregnancy is safe (Kaplan et al. 2015). People who are pregnant, trying to conceive or breastfeeding should not use retinoids on the scalp without medical advice. Tretinoin is a prescription medicine; discuss scalp use with a prescriber.

References

Leyden, J. J., Grossman, R., & Nighland, M. (2008). Cumulative irritation potential of topical retinoid formulations. Journal of Drugs in Dermatology, 7(8 Suppl), s14–s18. https://pubmed.ncbi.nlm.nih.gov/18724650/

Motamedi, M., Chehade, A., Sanghera, R., & Grewal, P. (2022). A clinician’s guide to topical retinoids. Journal of Cutaneous Medicine and Surgery, 26(1), 71–78. https://pubmed.ncbi.nlm.nih.gov/34292058/

Rittié, L., Varani, J., Kang, S., Voorhees, J. J., & Fisher, G. J. (2006). Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via induction of heparin-binding EGF and amphiregulin in human skin in vivo. Journal of Investigative Dermatology, 126(4), 732–739. https://pubmed.ncbi.nlm.nih.gov/16470170/

Kwon, O. S., Pyo, H. K., Oh, Y. J., et al. (2007). Promotive effect of minoxidil combined with all-trans retinoic acid (tretinoin) on human hair growth in vitro. Journal of Korean Medical Science, 22(2), 283–289. https://pubmed.ncbi.nlm.nih.gov/17449938/

Yoo, H. G., et al. (2007). The additive effects of minoxidil and retinol on human hair growth in vitro. Biological and Pharmaceutical Bulletin, 30(1), 21–26. https://pubmed.ncbi.nlm.nih.gov/17202653

Sharma, A., Goren, A., Dhurat, R., et al. (2019). Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. Dermatologic Therapy, 32(3), e12915. https://pubmed.ncbi.nlm.nih.gov/30974011/

Shin, H. S., Won, C. H., Lee, S. H., et al. (2007). Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial. American Journal of Clinical Dermatology, 8(5), 285–290. https://pubmed.ncbi.nlm.nih.gov/17902730/

Kaplan, Y. C., Ozsarfati, J., Etwel, F., et al. (2015). Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis. British Journal of Dermatology, 173(5), 1132–1141. https://pubmed.ncbi.nlm.nih.gov/26215715/

DailyMed. Amnesteem (isotretinoin capsules) prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2cb63c9-f825-4991-9a2c-6260f1bbcc2c